Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $85.00 Analyst target: $153.43 Upside: 80.51%
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.
See the full interactive analysis & chart →Informational only — not investment advice.